stevenpaul, Author at European Medical Journal - Page 29 of 37

Chronic Urticaria: Clinical Characteristics, Epidemiology, and Impact on the Quality of Life of Patients

Chronic urticaria (CU) is a common skin condition defined as an urticaria lasting for more than 6 weeks. It is divided into chronic…

EMJ Dermatology 9.1 Feature Image

Blueberry Muffin Baby Secondary to a Ganglioneuroblastoma: A Case Report

Blueberry muffin baby (BMB) is a rare neonatal syndrome characterised by the presence of multiple purpuric skin nodules. It can be due to…

EMJ Dermatology 9.1 Feature Image

Features of the Course of Condyloma Acuminate in Women Against the Background of Herpesvirus Infections

Despite the widespread prevalence of the human papillomavirus (HPV) and the variety of clinical variants associated with carrying the…

Navigating the Current Treatment Landscape in Oesophageal Cancer with an Eye Toward the Future

The symposium featured three talks and a live Q&A session. First, the current patient journey and standards of care in oesophageal cancer…

ESMO: Reshaping the Future of Clinical Trials in Oncology

Opening the session, Calvo presented a compelling and balanced case about the potential that Phase 0 (Ph0) trials hold for increasing…

Editor’s Pick: Imaging of Ovarian Cancer

This review provides a practical update of the role of imaging in every phase throughout the course of ovarian cancer. Read more.

Epidermal Growth Factor Receptor Inhibitor-Induced Hypomagnesaemia: Is There a Best Replacement Strategy?

Over the past few decades, there have been important advances in cancer therapeutics, including a shift from traditional cytotoxic…

Latest News and Advancements Within the Areas of Axial Spondyloarthritis and Psoriatic Arthritis Featured at EULAR 2021

The chronic inflammatory diseases axial spondyloarthritis (AxS) and psoriatic arthritis (PsA) involve symptoms such as axial skeleton pain…

Patient-Reported Outcomes with Monoclonal Antibody Therapies in Patients with Moderate-to-Severe Plaque Psoriasis

Richard B. Warren highlighted Psoriasis Symptoms and Impacts Measure (P-SIM) responses from the Phase III BE VIVID trial in patients…

Assessing Disease Activity and Progression in Patients with Relapsing–Remitting Multiple Sclerosis: Interviews with Two Key Opinion Leaders

Multiple sclerosis is a common and chronic neurological disorder that affects over 2.8 million individuals worldwide every year…